289 related articles for article (PubMed ID: 22699492)
21. The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.
Adak S; DeAndrade D; Pike LJ
J Biol Chem; 2011 Jan; 286(2):1545-55. PubMed ID: 21047778
[TBL] [Abstract][Full Text] [Related]
22. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis.
Nagy P; Claus J; Jovin TM; Arndt-Jovin DJ
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16524-9. PubMed ID: 20813958
[TBL] [Abstract][Full Text] [Related]
23. Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.
Shih AJ; Telesco SE; Choi SH; Lemmon MA; Radhakrishnan R
Biochem J; 2011 Jun; 436(2):241-51. PubMed ID: 21426301
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of activation and inhibition of the HER4/ErbB4 kinase.
Qiu C; Tarrant MK; Choi SH; Sathyamurthy A; Bose R; Banjade S; Pal A; Bornmann WG; Lemmon MA; Cole PA; Leahy DJ
Structure; 2008 Mar; 16(3):460-7. PubMed ID: 18334220
[TBL] [Abstract][Full Text] [Related]
25. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.
Franklin MC; Carey KD; Vajdos FF; Leahy DJ; de Vos AM; Sliwkowski MX
Cancer Cell; 2004 Apr; 5(4):317-28. PubMed ID: 15093539
[TBL] [Abstract][Full Text] [Related]
26. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
Mendrola JM; Berger MB; King MC; Lemmon MA
J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
[TBL] [Abstract][Full Text] [Related]
27. EGFR oligomerization organizes kinase-active dimers into competent signalling platforms.
Needham SR; Roberts SK; Arkhipov A; Mysore VP; Tynan CJ; Zanetti-Domingues LC; Kim ET; Losasso V; Korovesis D; Hirsch M; Rolfe DJ; Clarke DT; Winn MD; Lajevardipour A; Clayton AH; Pike LJ; Perani M; Parker PJ; Shan Y; Shaw DE; Martin-Fernandez ML
Nat Commun; 2016 Oct; 7():13307. PubMed ID: 27796308
[TBL] [Abstract][Full Text] [Related]
28. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.
Arteaga CL; Ramsey TT; Shawver LK; Guyer CA
J Biol Chem; 1997 Sep; 272(37):23247-54. PubMed ID: 9287333
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
[TBL] [Abstract][Full Text] [Related]
30. Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
Arkhipov A; Shan Y; Kim ET; Shaw DE
PLoS Comput Biol; 2014 Jul; 10(7):e1003742. PubMed ID: 25058506
[TBL] [Abstract][Full Text] [Related]
31. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
32. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
Jin P; Zhang J; Beryt M; Turin L; Brdlik C; Feng Y; Bai X; Liu J; Jorgensen B; Shepard HM
Mol Med; 2009; 15(1-2):11-20. PubMed ID: 19048033
[TBL] [Abstract][Full Text] [Related]
33. Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation - molecular dynamics study.
Motamedi Z; Rajabi-Maham H; Azimzadeh Irani M
J Mol Model; 2021 Nov; 27(12):361. PubMed ID: 34817689
[TBL] [Abstract][Full Text] [Related]
34. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.
Jura N; Shan Y; Cao X; Shaw DE; Kuriyan J
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21608-13. PubMed ID: 20007378
[TBL] [Abstract][Full Text] [Related]
35. Bivalence of EGF-like ligands drives the ErbB signaling network.
Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J
Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415
[TBL] [Abstract][Full Text] [Related]
37. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
[TBL] [Abstract][Full Text] [Related]
38. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.
Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C
J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710
[TBL] [Abstract][Full Text] [Related]
39. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
40. Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation.
Trenker R; Diwanji D; Bingham T; Verba KA; Jura N
Elife; 2024 Mar; 12():. PubMed ID: 38498590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]